[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@EliKorey Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1428015373.png) @EliKorey Eli Korey

Eli Korey posts on X about $ntla, $beam, $prme, goldman sachs the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1428015373/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1428015373/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX +432%
- X Months XXXXXX +357%
- X Year XXXXXX +677%

### Mentions: X [#](/creator/twitter::1428015373/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1428015373/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month XX -XX%
- X Months XXX +273%
- X Year XXX +330%

### Followers: XXX [#](/creator/twitter::1428015373/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1428015373/c:line/m:followers.svg)

- X Week XXX +1.90%
- X Month XXX +1.90%
- X Months XXX +37%
- X Year XXX +42%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1428015373/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1428015373/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [cryptocurrencies](/list/cryptocurrencies)  [finance](/list/finance) 

**Social topic influence**
[$ntla](/topic/$ntla) #6, [$beam](/topic/$beam) #59, [$prme](/topic/$prme) #21, [goldman sachs](/topic/goldman-sachs), [bearish](/topic/bearish), [the first](/topic/the-first), [at least](/topic/at-least), [$regn](/topic/$regn), [$arwrs](/topic/$arwrs), [$wve](/topic/$wve)

**Top accounts mentioned or mentioned by**
[@geneinvesting](/creator/undefined) [@winfieldsmart](/creator/undefined) [@ricfulop](/creator/undefined) [@miketrades2020](/creator/undefined) [@rnaianalyst](/creator/undefined) [@3primeanalytica](/creator/undefined) [@adamomancino](/creator/undefined) [@sunrgu](/creator/undefined) [@jaden88743797](/creator/undefined) [@mastermaxclan](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@yusufhameed](/creator/undefined) [@germandave0912](/creator/undefined) [@devineni6](/creator/undefined) [@crisprspace](/creator/undefined) [@stockwatchsthlm](/creator/undefined) [@brendancollin17](/creator/undefined) [@amaymd](/creator/undefined) [@jefferies](/creator/undefined) [@michaelmaiello](/creator/undefined)

**Top assets mentioned**
[Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [BEAM (BEAM)](/topic/$beam) [Goldman Sachs (GS)](/topic/goldman-sachs) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Pfizer, Inc. (PFE)](/topic/$pfe) [Novo-Nordisk (NVO)](/topic/$nvo)
### Top Social Posts
Top posts by engagements in the last XX hours

"Things that make you go hmmm: GS biotech analyst has been bearish on $NTLA all year rating of sell from neutral and pt $X since Feb '25. The PT was lowered to $X while keeping the sell rating in May '25. Yet the Goldman Sachs Group has been increasing its stake all year and"  
[X Link](https://x.com/EliKorey/status/1994042011868123412)  2025-11-27T13:53Z XXX followers, 1339 engagements


"With the FDA stating that the standard will now be only X pivotal trial required for approval will $ntla look to file a BLA on Lonvo-z based on their phase X data instead of waiting until after p3 data in 1h '26. They could shave X months from their timeline"  
[X Link](https://x.com/EliKorey/status/1996610445373743372)  2025-12-04T16:00Z XXX followers, XX engagements


"@MichaelMaiello @Bicep_crypto If the FDA did deliver the clinical hold letter on the 30th day following initial communication of such action then $NTLA has until the end of today to file an 8k"  
[X Link](https://x.com/EliKorey/status/1996595095932481663)  2025-12-04T14:59Z XXX followers, XXX engagements


"If we do not see an 8k from $NTLA by the end of today The FDA will have missed their XX day requirement. Then the obvious question will be. how much of a delay will occur Did the govt shutdown cause the delay or simply the chaos with this current FDA"  
[X Link](https://x.com/EliKorey/status/1996956957245059171)  2025-12-05T14:56Z XXX followers, XXX engagements


"$BEAM dosed the first patient in their beam-302 trial for AATD on June 26th 2024. $PRME will be lucky to dose their first patient by the end of q3 of 2026 assuming the win in arbitration. Two years behind is not my definition of being "not that far behind""  
[X Link](https://x.com/EliKorey/status/1997044225918357866)  2025-12-05T20:43Z XXX followers, XXX engagements


"@3primeAnalytica @GeneInvesting Exactly. $prme will be at least X years behind $beam and at least X months behind Tessera/$regn. They could be in a box and needing the courts to help them in ultimately competing in this ever growing crowded indication"  
[X Link](https://x.com/EliKorey/status/1995598212917592252)  2025-12-01T20:57Z XXX followers, XXX engagements


"If $ARWR's upcoming INHBE data in January confirms what we just saw reported by $WVE I wonder how quickly big pharma might move in. We all know that $PFE and $NVO are a bit desperate"  
[X Link](https://x.com/EliKorey/status/1998020335652991384)  2025-12-08T13:22Z XXX followers, XXX engagements


"The warm reception many biotech companies are receiving on capital raises is a far cry from the last few years. This brings me to $NTLA granted the unfortunate SAE killed any chance of them raising funds following the outstanding data on ATTR and HAE but let's be honest"  
[X Link](https://x.com/EliKorey/status/1998406595701621199)  2025-12-09T14:57Z XXX followers, XXX engagements